OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2010
(4)
2021
(1)
2020
(1)
2017
(1)
2016
(1)
2015
(1)
2011
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts.
Not available
S-EPMC7429152
|
biostudies-literature
Cite
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.
Not available
S-EPMC4319990
|
biostudies-literature
Cite
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.
Not available
S-EPMC5638008
|
biostudies-literature
Cite
Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices.
Not available
S-EPMC8042019
|
biostudies-literature
Cite
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Not available
S-EPMC4123233
|
biostudies-literature
Cite
Effects of combination lipid therapy in type 2 diabetes mellitus.
Not available
S-EPMC2879499
|
biostudies-literature
Cite
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
Not available
S-EPMC4123215
|
biostudies-literature
Cite
Long-term effects of intensive glucose lowering on cardiovascular outcomes.
Not available
S-EPMC4083508
|
biostudies-literature
Cite
Effects of medical therapies on retinopathy progression in type 2 diabetes.
Not available
S-EPMC4026164
|
biostudies-literature
Cite
Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response.
Not available
S-EPMC5013254
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets